Check Reviva Pharmaceuticals Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$26.9M
EPS (TTM)
-0.48
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-10.1M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
13831800.00%
Compare market cap, revenue, PE, and other key metrics of Reviva Pharmaceuticals Holdings with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $26.9M | NA | NA | 0.00% | |
BUY | $60.5B | 248.74% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Reviva Pharmaceuticals Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Reviva Pharmaceuticals Holdings investment value today
Current value as on today
₹34,663
Returns
Returns from Reviva Pharmaceuticals Holdings Stock
Dollar Returns*
₹4,953 (+4.95%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Reviva Pharmaceuticals Holdings. Average target price of $7
Get share price movements and forecasts by analysts on Reviva Pharmaceuticals Holdings.
What analysts predicted
94.14%UPSIDE
Target Price
$7
Current Price
$0.41
Analyzed by
11 Analysts
Target
$7.00
Reviva Pharmaceuticals Holdings target price $7, a slight upside of 94.14% compared to current price of $0.41. According to 11 analysts rating.
Investment in Reviva Pharmaceuticals Holdings Shares on INDmoney has dropped by -15.49% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Reviva Pharmaceuticals Holdings Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 139.1%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 194.3%
Price Dip
In the last 7 days, RVPH stock has moved down by -8.8%
Organisation | Reviva Pharmaceuticals Holdings |
Headquarters | 10080 N. Wolfe Road, Cupertino, CA, United States, 95014 |
CEO | Dr. Laxminarayan Bhat Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Laxminarayan Bhat Ph.D. | Founder, CEO, President & Director |
Mr. Narayan Prabhu | Chief Financial Officer |
Reviva Pharmaceuticals Holdings share price today is $0.41 as on at the close of the market. Reviva Pharmaceuticals Holdings share today touched a day high of $0.44 and a low of $0.4.
Reviva Pharmaceuticals Holdings share touched a 52 week high of $4.28 on and a 52 week low of $0.3 on . Reviva Pharmaceuticals Holdings stock price today i.e. is closed at $0.41,which is 90.42% down from its 52 week high and 36.67% up from its 52 week low.
Reviva Pharmaceuticals Holdings market capitalisation is $0.00T as on .
Indian investors can start investing in Reviva Pharmaceuticals Holdings (RVPH) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Reviva Pharmaceuticals Holdings stock (as per the Rupee-Dollar exchange rate as on ).
Based on Reviva Pharmaceuticals Holdings share’s latest price of $0.41 as on September 18, 2025 at 1:29 am IST, you will get 24.3902 shares of Reviva Pharmaceuticals Holdings. Learn more about
fractional shares .